Emerging Protein Bio Therapeutics

Therapeutic proteins and monoclonal antibodies (MAb) have transformed biotechnology and the pharmaceutical industry. Together they form the largest part of the rapidly growing biologics drug market. Protein-based drugs include blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferons, interleukins, tumor necrosis factor, and therapeutic enzymes. 

  • Protein Particulate Detection Issues in Biotherapeutics Development
  • Analytical Development For Emerging Biotherapeutics
  • Automation And Emerging Analytical Methods
  • Bioanalytical Considerations Of Multi-Domain Biotherapeutics: Preclinical And Clinical Development

Related Conference of Emerging Protein Bio Therapeutics

September 13-14, 2018

World Conference on Vaccine and Immunology

Bucharest, Romania
September 13-14, 2018

11th Annual Congress on Immunology & Immunotechnology

Zurich, Switzerland
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 20-21, 2018

Global Meet on Immunology and Molecular Biology

Oslo, Norway
October 19-20, 2018

10th World Congress and Expo on Immunology

New York, USA
October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland
December 06-07, 2018

Annual Congress and Expo on Antibiotics

Amsterdam, Netherlands
March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain

Emerging Protein Bio Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in